SCPHARMACEUTICALS INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 10 rows in 2017. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-12-19: Reporting owner SCHAEFFER LEONARD D; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2017-11-21: Reporting owner VEITINGER KLAUS R DR; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2017-11-16: Reporting owner Khattar Jack A.; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2017-11-16: Reporting owner SCHAEFFER LEONARD D; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-12-19 | SCHAEFFER LEONARD D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −22,631 5,223 owned after | $1.66 exercise price | 2017-12-20 | |
| 2017-11-21 holding as of filing | VEITINGER KLAUS R DR Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $5.89 exercise price | 2017-11-21 | ||
| 2017-11-16 holding as of filing | Khattar Jack A. Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $8.84 exercise price | 2017-11-16 | ||
| 2017-11-16 holding as of filing | SCHAEFFER LEONARD D Director | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $1.66 exercise price | 2017-11-16 | ||
| 2017-11-16 holding as of filing | Coleman Dorothy Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $8.12 exercise price | 2017-11-16 | ||
| 2017-11-16 holding as of filing | Ceesay Abraham Officer (Chief Operating Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $8.84 exercise price | 2017-11-16 | ||
| 2017-11-16 holding as of filing | Ceesay Abraham Officer (Chief Operating Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.81 exercise price | 2017-11-16 | ||
| 2017-11-16 holding as of filing | Ignelzi Troy A. Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $8.84 exercise price | 2017-11-16 | ||
| 2017-11-16 holding as of filing | Ignelzi Troy A. Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.81 exercise price | 2017-11-16 | ||
| 2017-11-16 holding as of filing | Tucker John H Director, Officer (President and CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.81 exercise price | 2017-11-16 |